Weeks after the Food and Drug Administration (FDA) approved Pfizer-BioNTech coronavirus booster shots for elderly and vulnerable Americans, the agency has now approved the Moderna and Johnson & Johnson booster shots for those same demographics.
In an announcement on Wednesday, the FDA said that a single dose of the Moderna booster shots will be authorized for the following demographics:.
Going a step further, the FDA approved a “mix & match” strategy by allowing people to receive a booster shot of their choosing, meaning people who received the Pfizer-BioNTech vaccine can now receive a Moderna or J&J booster shot.